TPG Asia to Sell 14.7% Stake in Sai Life Sciences; Stock Tanks Nearly 5%

Mumbai, August 26, 2025: The shares price of Sai Life Sciences Ltd (NSE: SAILIFE) declined sharply on Tuesday, slipping by 4.68% to ₹864.50 at 01:45 PM. This fall is largely attributed to reports that private equity investor TPG Asia is looking to offload up to 14.72% stake (around 3.07 crore shares) in the company through a block deal.

Primary Reason for the Fall

The stock was under tremendous selling pressure since the opening bell amid the reports of the large block deal, including TPG Asia. This deal is expected to increase the stock supply, thereby putting downward pressure on the stock price. The block deal is approximately one seventh of the company, and the report has triggered selling sentiment among the investors, even while the company had just touched the 52-week high price (₹943.00) on August 25, 2025.

Sai Life Sciences: Stock Price Movement

At 01:45 PM, the stock traded at ₹864.50 (4.68% down from the previous day’s closing price). The low-high range remained between ₹853.70 and ₹879.00. The trading volume was quite high, with over 4.46 crore shares traded so far, with 64% sellers. The stock has surged close to 19.50% in the past three months. The scrip recently hit a 52-week high of ₹943 (25 Aug 2025) and a low of ₹636.10 (9 Apr 2025).

The company’s market cap is ₹18,172.64 crore, free float market cap at ₹5,603.24 crore, and it trades at a steep P/E ratio of 129.83.

Listed on the bourses in December 2024, Sai Life Sciences Ltd is a pharmaceutical company operating in the Nifty Smallcap 250 index. It specialises in drug discovery, development, and manufacturing solutions for global innovators.

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations